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Background: Dyslipidemia increases circulating levels of oxidized low-density lipoprotein (OxLDL) and this may
induce alveolar bone loss through toll-like receptor (TLR) 2 and 4. The purpose of this study was to investigate the
effects of dyslipidemia on osteoclast differentiation associated with TLR2 and TLR4 in periodontal tissues using a rat
dyslipidemia (apolipoprotein E deficient) model.
Methods: Levels of plasma OxLDL, and the cholesterol and phospholipid profiles in plasma lipoproteins were
compared between apolipoprotein E-deficient rats (16-week-old males) and wild-type (control) rats. In the
periodontal tissue, we evaluated the changes in TLR2, TLR4, receptor activator of nuclear factor kappa B ligand
(RANKL) and tartrate resistant acid phosphatase (TRAP) expression.
Results: Apolipoprotein E-deficient rats showed higher plasma levels of OxLDL than control rats (p<0.05), with
higher plasma levels of total cholesterol (p<0.05) and LDL-cholesterol (p<0.05) and lower plasma levels of high-
density lipoprotein cholesterol (p<0.05). Their periodontal tissue also exhibited a higher ratio of RANKL-positive cells
and a higher number of TRAP-positive osteoclasts than control rats (p<0.05). Furthermore, periodontal gene
expression of TLR2, TLR4 and RANKL was higher in apolipoprotein E-deficient rats than in control rats (p<0.05).
Conclusion: These findings underscore the important role for TLR2 and TLR4 in mediating the osteoclast
differentiation on alveolar bone response to dyslipidemia.
Keywords: Apolipoprotein E-deficient model, Alveolar bone, Toll-like receptor 2, Toll-like receptor 4, Osteoclast
differentiationBackground
Periodontal disease is a chronic inflammatory disease of
the tooth-supporting structures. Studies have confirmed
a positive association between periodontal disease and
dyslipidemia. For instance, it has been reported that
patients with dyslipidemia showed a significantly higher
number of sextants with increased periodontal pockets
than the control group [1]. It is also known that the ratio
of high-density lipoprotein (HDL) to total cholesterol is* Correspondence: dekuni7@md.okayama-u.ac.jp
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reproduction in any medium, provided the orassociated with gingival index and percentage of
bleeding on probing in patients with dyslipidemia [2].
Furthermore, it is shown that plasma level of lipid
peroxidation was associated with the severity of pe-
riodontal disease in type 2 diabetes patients [3]. Al-
though the cause of periodontal disease is oral bacterial
pathogens (e.g., lipopolysaccharide [LPS]), it is concei-
vable that dyslipidemia contributes to the destructive
aspects of the host response against bacterial pathogens
that leads to periodontal disease, including alveolar bone
loss.
Dyslipidemia increases the risk for overproduction of
reactive oxygen species (ROS) in multiple organs [4],al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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anti-oxidative balance that contributes to increased blood
levels of oxidized low-density lipoprotein (OxLDL) [5].
Studies have demonstrated that OxLDL modulates toll-
like receptor (TLR) expression and signaling [6,7]. TLR2
and TLR4 are critical receptors and signal transducers for
oral bacterial LPS [8,9], and activate receptor activator of
nuclear factor kappa B ligand (RANKL) expression [10],
resulting in osteoclast differentiation in alveolar bone [11].
Therefore, it is possible that increased OxLDL following
dyslipidemia advances periodontal disease through osteo-
clast differentiation via TLR signaling.
We previously found that diet-induced dyslipidemia is
able to induce alveolar bone loss [12-14]. However, the
role of TLR in dyslipidemia-induced alveolar bone loss
has not been determined. In the present study, we
hypothesized that the increased OxLDL in dyslipidemia
may induce osteoclast differentiation on alveolar bone
through TLR signaling. The apolipoprotein E (apoE)-
deficient animal model is known to develop dyslipidemia
[15-17]. Thus, the purpose of this study was to investigate
the effects of dyslipidemia on osteoclast differentiation
and TLR expression in periodontal tissue using an apoE-
deficient rat model. To gain better insight into the me-
chanism of action, we analyzed histological changes and
changes in TLR2, TLR4 and RANKL expression. In
addition, expression of interleukin (IL)-1β in the pe-
riodontal tissue was evaluated as a parameter of periodon-
tal inflammation activity.Materials and methods
Animals
Control (wild-type) and dyslipidemic (apoE-deficient)
rats (all Sprague–Dawley strain background; each group,
n=6; age, 15 weeks) were obtained from Sigma Labora-
tory (St. Louis, MO). All experimental procedures were
performed in compliance with guidelines approved by
the Animal Research Control Committee of Okayama
University Graduate School of Medicine, Dentistry and
Pharmaceutical Sciences (OKU-2011004). Animals were
maintained under standard conditions and given free ac-
cess to food (MF; Oriental Yeast Co. Ltd., Osaka, Japan)
and drinking water. The 7-day experiment was carried
out at the same time for all groups. Collection of blood,Table 1 Primer sequences for IL-1β, RANKL, TLR2, TLR4 and β





β-actin TGTTGCCCTAGACTTCGAGCA GGACCCAGGAsacrifice of rats and periodontal tissue isolation were
performed as described previously [18].
Histological analysis
For histological analysis, the maxillary molar regions
(tooth and periodontal tissues) were resected en bloc
from each rat and were immediately fixed in 4%
paraformaldehyde in 0.1 mol/l phosphate buffer (pH 7.4)
for 1 day. Tooth and periodontal tissues were decalcified
with 10% tetrasodium-ethylenediaminetetraacetic acid
aqueous solution (pH 7.4) for 8 weeks at 4°C. Paraffin-
embedded bucco-lingual sections (4 μm) were stained
with hematoxylin and eosin or other stains, as described
below.
Immunostaining for lipid A, TLR2, TLR4 and RANKL
were performed using a commercial kit (Histofine Simple
Stain MAX PO; Nichirei Co., Tokyo, Japan). Monoclonal
antibodies against TLR2 (Bioss Inc., Woburn, MA) and
TLR4 (Santa Cruz Biotechnology, CA) and polyclonal anti-
body against RANKL (Santa Cruz Biotechnology) were
diluted at 1/200, 1/300 and 1/100 in phosphate buffered
saline, respectively. Color was developed by placing sections
in a solution of 3-3’-diaminobenzidine tetrahydrochloride.
To identify osteoclasts, tartrate-resistant acid phospha-
tase (TRAP) activity was also detected using the azo
dye method [18]. Sections were counterstained with
Mayer’s hematoxylin.
A single examiner (T. T.), blinded to the treatment as-
signment, performed histometric analyses using a micro-
scope (Olympus Co., Tokyo, Japan). The distances
between the cemento-enamel junction and the alveolar
bone crest (an indicator of alveolar bone loss) were
measured using a microgrid at a magnification of ×200
[12,18]. RANKL-positive osteoblasts, total osteoblasts and
TRAP-positive osteoclasts on the surface of alveolar bone
were counted using a light microscope at ×400 magnifica-
tion and are reported in terms of number/millimeters
[13,14]. We evaluated intra-examiner reproducibility by
double-scoring 10 randomly selected sections at two-week
intervals. Agreement for RANKL-positive cells and
TRAP-positive osteoclasts was more than 90%.
Gene expression analyses
Total RNA was extracted from periodontal tissue
samples using a commercial reagent (Invitrogen). The-actin






Figure 1 Hematoxylin and eosin staining of rat periodontal
tissue at 7 days. No pathological changes were observed in the
periodontium in any of the samples in the control group (A). The
dyslipidemia group showed extension of blood vessels, root
resorption (white arrows) and the increased number of inflammatory
cells subjacent to the junctional epithelium (JE) (black arrows) (B).
AB, alveolar bone and CM, cementum. Original magnification × 10.
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ance ratio, and only samples with a ratio greater than 1.8
were used. Samples (2 μg) of total RNA from each
group, which was reverse transcribed by AMV Reverse
Transcriptase (TAKARA, Kyoto, Japan) at 42°C for
30 min, were used to perform first-strand cDNA synthe-
sis using a commercial kit (Roche, Tokyo, Japan). cDNA
prepared as described above was diluted 10-fold with
yeast RNA (10 μg/mL). Primer sequences for the genes
encoding rat TLR2, TLR4, RANKL, IL-1β and β-actin
are shown in Table 1. Cycling conditions using
TOYOBO SYBR Green PCR Master Mix (TOYOBO,
Osaka, Japan) in a LightCycler™ (Roche Applied Science,
Mannheim, Germany) system were as follows: 95°C for
30 s, 59°C for 30 s and 72°C for 30 s for 45 cycles.
mRNA levels were expressed in terms of relative copyTable 2 Histopathological evaluation in periodontal tissues (m
Polymorphonuclear leukocytes (numbers/0.05 mm x 0.1 mm)
Distance between the cemento-enamel junction and the alveolar bone crest
Ratio of RANKL-positive cells
TRAP-positive osteoclasts (numbers/mm)
a Significantly different from the Control group, p < 0.05 (t-test).number ratio for TLR2, TLR4, RANKL or IL-1β against
β-actin for each sample. Gene expression in the
dyslipidemia group was calculated in terms of relative
copy number ratio for each mRNA against the control
group for each sample.
Analysis of blood samples
Blood samples were collected from the heart at age 8 -
weeks. Blood was allowed to clot at room temperature,
and plasma was separated by centrifugation at 1,500 ×g
for 15 min. Levels of plasma OxLDL were measured
using an ELISA kit (Cusabio Biotech Co., Ltd., Wuhan,
China) [19]. The cholesterol and phospholipid profiles in
plasma lipoproteins were analyzed using a dual detection
high-performance liquid chromatography system at Sky-
light Biotech (Akita, Japan) [20]. We quantified indivi-
dual subfractions using best curve fitting analysis,
assuming that the particle sizes for all subfractions
followed a Gaussian distribution. Particle sizes for indi-
vidual subfractions were determined as 30–80 nm (very
low-density lipoprotein [VLDL]), 16–30 nm (LDL) and
8–16 nm (HDL).
Statistical analysis
All data are expressed as means ± S.D. Comparisons be-
tween the dyslipidemia and control groups were
performed by independent t-test using a statistical soft-
ware package (SPSS 17.0 J for Windows, IBM, Tokyo,
Japan). A p value of < 0.05 was accepted as statistically
significant. Sample size was calculated using the nQuery
Advisor (Statistical Solutions, Saugus, MA), based on
the results of our previous studies [13,14]. A sample size
of 6 per group was required for detection of significant
differences (80% power, two-sided, 5% significance
level).
Results
No significant differences were observed between the
control and dyslipidemia groups with regard to food
consumption, body weight or growth pattern during the
7-day period.
In the dyslipidemia group, periodontal tissues showed
extension of blood vessels, root resorption and increased





0.7 ± 0.5 2.1 ± 0.5a
(μm) 571 ± 100 618 ± 42
0.18 ± 0.05 0.41 ± 0.07a
2.3 ± 2.2 7.9 ± 2.7a
Figure 3 Immunohistochemical staining for RANKL and TRAP in
the periodontal tissue. The dyslipidemia group (B) showed higher
expressions of RANKL and TRAP (arrows) compared to the control
group (A). Original magnification × 40.
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(Figure 1). The numbers of polymorphonuclear
leukocytes, RANKL-positive osteoblasts and TRAP-
positive osteoclasts in the dyslipidemia group were also
higher than those in the control group (p< 0.05)
(Table 2). Furthermore, the periodontium in the
dyslipidemia group showed high expression of TLR2,
TLR4, RANKL, and TRAP, as compared to the control
group (Figures 2 and 3). In addition, although the
dyslipidemia group showed greater distances between
the cemento-enamel junction and alveolar bone crest
than the control group, this difference was not
statistically significant.
Gene expression of TLR2, TLR4 and RANKL was 1.90,
1.37, and 1.52 times higher in periodontal tissues
obtained from the dyslipidemia group than in those
obtained from the control group, respectively (p < 0.05)
(Figure 4). Gene expression of IL-1β in periodontal
tissues was also higher in the dyslipidemia group than
that in the control group (p < 0.05).
At 7 days, plasma levels of OxLDL were 2.31 times
higher in the dyslipidemia group than in the control
group (p < 0.05) (Table 3). Plasma levels of total choles-
terol, VLDL cholesterol and LDL cholesterol were alsoFigure 2 Immunohistochemical staining for TLR-2 (A and B)
and TLR-4 (C and D) in the periodontal tissue. The dyslipidemia
group (B and D) showed higher expressions of TLR2 and TLR4
compared to the control group (A and C), respectively. Original
magnification × 20.higher in the dyslipidemia group than in the control
group (p < 0.05). On the other hand, plasma HDL cho-
lesterol levels were lower in the dyslipidemia group than
in the control group (p < 0.05).
Discussion
The apoE-deficient rats showed higher plasma levels of
total cholesterol, LDL cholesterol and VLDL cholesterol,
and lower plasma levels of HDL cholesterol, asFigure 4 Fold changes of gene expression on rat periodontal
tissue (mean ± SD). The mRNA levels were calculated in terms of
the relative copy number ratio of each mRNA to β-actin for each
sample (n=6 per group). All values in the dyslipidemia group were
significantly higher than those in the control group (p < 0.05).






Total cholesterol (mg/dL) 40.8 ± 6.6 130.8 ± 25.0a
VLDL cholesterol (mg/dL) 7.1 ± 1.2 54.2 ± 11.6a
LDL cholesterol (mg/dL) 13.6 ± 1.9 51.4 ± 11.6a
HDL cholesterol (mg/dL) 31.5 ± 4.9 10.2 ± 1.3a
OxLDL (ng/mL) 13.7 ± 3.0 31.7 ± 6.3a
a Significantly different from the control group, p < 0.05 (t-test).
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exhibited dyslipidemia in this study. In addition, the
periodontal tissues in the apoE-deficient rats exhibited
higher expression levels of TLR2, TLR4, RANKL and
TRAP than those in the control rats. TLR activates
RANKL expression [10], resulting in osteoclast differen-
tiation [11]. It is possible that dyslipidemic conditions
are associated with TLR-induced osteoclast differen-
tiation in periodontal tissues.
Previous studies have demonstrated that OxLDL has
direct effects on TLR2 and TLR4 expression [6,7]. In
this study, dyslipidemic conditions induced higher plasma
levels of OxLDL than normal conditions. Increased plasma
levels of OxLDL following dyslipidemic conditions may
induce increased expression of TLR2 and TLR4. TLR 2
and 4 are critical receptors for oral bacterial LPS [8,9].
Dyslipidemic conditions would alter the interaction be-
tween bacterial pathogens and the cellular membrane,
by increasing plasma levels of OxLDL.
In this study, dyslipidemic conditions were associated
with higher plasma levels of total cholesterol, LDL choles-
terol and VLDL cholesterol, and lower plasma levels of
HDL cholesterol when compared with normal conditions.
In clinical studies, it has been shown associations between
blood lipid parameters and periodontal condition [21-23].
Therefore, it is also possible that impaired plasma lipids
had direct effects on TLR2 and TLR4 expression in the
current model. However, we previously found that changes
in osteoclast differentiation under hypercholesterolemic
conditions did not depend on blood lipids [13,24]. This
suggests that impaired lipids do not play a crucial role in
TLR2 and TLR4 expression in the periodontal tissue.
It has been reported that activation of TLR2 and TLR4
promotes expression of inflammatory cytokines [25,26].
In the present study, dyslipidemic conditions induced
gene expression of IL-1β, an inflammatory cytokine. In-
flammatory cytokines promote osteoclast differentiation
both directly and indirectly [27]. These observations
indicate that the increased osteoclast differentiation under
dyslipidemic conditions is partly caused by induction of
inflammatory cytokines. Furthermore, overproduction
of inflammatory cytokines can stimulate inflammatoryresponses [28], and this would advance periodontal in-
flammation. In fact, inflammatory histological changes,
such as increased number of polymorphonuclear leukocytes
and root resorption, were also observed in the current
dyslipidemia model.
In our previous study [14], hypercholesterolemic rats
(age, 20 weeks) fed a high-cholesterol diet for 8 weeks
showed increased numbers of RANKL-positive cells on
the alveolar bone surface. In that study, the ratio of
RANKL-positive cells to total cells (mean ± SD) was
0.15 ± 0.04 in the control group and 0.32 ± 0.10 in the
hypercholesteromic group [14]. In the present study
using an apoE-deficient model (age, 16 weeks), the ratio
of RANKL-positive cells to total cells (mean ± SD) was
0.18 ± 0.05 in the control group and 0.41 ± 0.07 in the
dyslipidemic group. These results are in agreement with
previous findings that impaired lipid metabolism induces
RANKL expression.
Studies have shown positive association between
dyslipidemia and periodontal disease [21,29,30]. In our
previous animal study, feeding with a high-cholesterol
diet increased serum lipid peroxidation and the number
of TRAP-positive osteoclasts, with an increase in
RANKL expression [14]. In this study, we demonstrated
that activation of TLR2 and TLR4 is involved in osteo-
clast differentiation on the surface of alveolar bone
under dyslipidemic conditions. Therefore, suppression of
TLR expression may be an effective method for
preventing osteoclast differentiation under dyslipidemic
conditions. However, further studies are necessary.
Our study has several limitations. As the bacterial flora
in the gingival sulcus of rats differs from that in humans,
we did not investigate how dyslipidemic conditions
directly affect bacterial flora. More studies are thus ne-
cessary in order to clarify this issue. In addition, although
osteoclast differentiation increased under dyslipidemic
conditions, the linear distance between the cemento-
enamel junction and alveolar bone crest did not change
in our model. As the experimental period was only 7 days,
long-term analysis is necessary.
In conclusion, dyslipidemia induces osteoclast differ-
entiation on the alveolar bone surface by activation of
TLR2 and TLR4 in the rat apolipoprotein E knockout
model.Abbreviations
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